Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00220688
Other study ID # SRC1
Secondary ID
Status Completed
Phase N/A
First received September 16, 2005
Last updated October 13, 2009
Start date September 2005
Est. completion date October 2006

Study information

Verified date March 2007
Source Gloucestershire Hospitals NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

Randomised controlled trial of acupressure wrist bands for hospice in-patients suffering from terminal cancer who are troubled by nausea and vomiting.


Description:

Pilot The study will be piloted with 10 patients to ensure that the protocol is acceptable to patients and to inform a formal power calculation for a larger study. Patients will be randomized to each arm according to a randomization programme at www.randomization.com.

Arm 1 Instruction and placement of acupressure bands at the P6 acupuncture point bilaterally. This point is located 2 cun (a Chinese measurement equal to approximately 3cm) proximal to the midpoint of the transverse crease of the wrist between the tendons of palmaris longus and flexor carpi radialis.

Arm 2 Instruction and placement of sham acupressure bands P6 acupuncture point bilaterally. Sham acupressure bands have no stud to stimulate P6.

Patients may choose to have regular anti-emetics or a subcutaneous syringe driver after 24 hours if they are not happy with their level of nausea and vomiting.

4. STUDY POPULATION

4.1 Source and Number of Patients: Hospice in-patients. 10 patients for pilot.

4.2 Inclusion Criteria

Patients must meet the following criteria to be eligible to participate in the study:

1. Have a diagnosis of advanced cancer with an estimated prognosis of less than 1 year but more than 3 days.

2. Describe their nausea as at least moderate on a Likert scale OR at have had at least one vomit per day for the last three days.

3. Have an underlying cause for their nausea which is thought to be irreversible OR the patient has made an autonomous choice not to proceed with treatment for any potentially reversible cause (for example surgery for obstruction or drainage of ascites).

4. Can be male or female patients but must be over the age of 18.

5. Have signed a consent form prior to entering the study.

6. If patients are taking corticosteroids the dosage should be stable for 3 days before and during the trial.

7. Be thought to be well enough to complete the 3 day trial.

4.3 Exclusion criteria

1. Arm lymphoedema.

2. Weakness, fatigue or confusion sufficient that patient is unable to take part.

3. Previous history of acupuncture/acupressure for nausea or vomiting.

4. History of Parkinsonism or Parkinsonism on examination.

5. Patients will not be enrolled if they are sharing a room with another patient taking part in the study.

5. OUTCOME MEASURES

1. Visual Analogue Scale of nausea measured every 6 hours. If patients are asleep they will not be waken for assessments overnight.

2. Duration of perceived nausea over preceding time period.

3. Number of vomits per 24 hours.

4. Volume of vomit per 24 hours.

5. Adverse effects of acupressure.

6. Number of doses of PRN anti-emetics.

7. Measure of whether the patient felt the intervention helped at the end of the trial.

6. QUANTITATIVE ANALYSIS

This pilot will allow a formal power calculation to be performed to elucidate how many patients need to be randomized to the full study.

Statistical analysis will be performed by Sarah Vowler at the Centre for Applied Medical Statistics.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date October 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Have a diagnosis of advanced cancer with an estimated prognosis of less than 1 year but more than 3 days.

- Describe their nausea as at least moderate on a Likert scale OR at have had at least one vomit per day for the last three days.

- Have an underlying cause for their nausea which is thought to be irreversible OR the patient has made an autonomous choice not to proceed with treatment for any potentially reversible cause (for example surgery for obstruction or drainage of ascites).

- Can be male or female patients but must be over the age of 18.

- Have signed a consent form prior to entering the study.

- If patients are taking corticosteroids the dosage should be stable for 3 days before and during the trial.

- Be thought to be well enough to complete the 3 day trial.

Exclusion Criteria:

- Arm lymphoedema.

- Weakness, fatigue or confusion sufficient that patient is unable to take part.

- Previous history of acupuncture/acupressure for nausea or vomiting.

- History of Parkinsonism or Parkinsonism on examination.

- Patients will not be enrolled if they are sharing a room with another patient taking part in the study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Acupressure Wristbands


Locations

Country Name City State
United Kingdom Sue Ryder Care St. John's Hospice Moggerhanger Bedfordshire

Sponsors (1)

Lead Sponsor Collaborator
Gloucestershire Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Brown S, North D, Marvel MK, Fons R. Acupressure wrist bands to relieve nausea and vomiting in hospice patients: do they work? Am J Hosp Palliat Care. 1992 Jul-Aug;9(4):26-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary 1.Visual Analogue Scale of nausea measured every 6 hours.
Secondary Duration of perceived nausea over preceding time period.
Secondary Number of vomits per 24 hours.
Secondary Volume of vomit per 24 hours.
Secondary Adverse effects of acupressure.
Secondary Number of doses of PRN anti-emetics.
Secondary Measure of whether the patient felt the intervention helped at the end of the trial.
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients